Skip to main navigation
Skip to main content
Denali Therapeutics
  • Home
  • Scientific Approach
    • GENETIC PATHWAY POTENTIAL
    • ENGINEERING BRAIN DELIVERY
    • BIOMARKER-DRIVEN DEVELOPMENT
    • PUBLICATIONS
  • Pipeline
  • Patients
  • Investor & Media Relations
    • Press Releases
    • Events
    • SEC Filings
    • Corporate Governance
    • Analyst Coverage
  • Leadership
  • Partnering
  • Careers
    • Job Openings
    • STEM Outreach Overview
    • Student Internships
    • Postdoc Program
  • Contact

SEC Filings

Sign Up For Updates
Filing date Form Description View
Dec 07, 2017 3 Initial filing by director officer or owner of more than ten percent. View HTML
0000899243-17-028190.pdf
0000899243-17-028190.rtf
Dec 07, 2017 3 Initial filing by director officer or owner of more than ten percent. View HTML
0001209191-17-064533.pdf
0001209191-17-064533.rtf
Dec 07, 2017 3 Initial filing by director officer or owner of more than ten percent. View HTML
0001209191-17-064536.pdf
0001209191-17-064536.rtf
Dec 07, 2017 3 Initial filing by director officer or owner of more than ten percent. View HTML
0001209191-17-064538.pdf
0001209191-17-064538.rtf
Dec 07, 2017 3 Initial filing by director officer or owner of more than ten percent. View HTML
0001209191-17-064539.pdf
0001209191-17-064539.rtf
Dec 07, 2017 3 Initial filing by director officer or owner of more than ten percent. View HTML
0001209191-17-064542.pdf
0001209191-17-064542.rtf
Dec 07, 2017 EFFECT EFFECT View HTML
9999999995-17-003174.pdf
9999999995-17-003174.rtf
Dec 04, 2017 CORRESP CORRESP View HTML
0001193125-17-360366.pdf
0001193125-17-360366.rtf
0001193125-17-360366.xls
Dec 04, 2017 CORRESP CORRESP View HTML
0001193125-17-360373.pdf
0001193125-17-360373.rtf
0001193125-17-360373.xls
Dec 01, 2017 CERTNAS CERTNAS View HTML
Pagination
  • First page «
  • Previous page ‹
  • …
  • Page 69
  • Page 70
  • Current page 71
  • Page 72
  • Page 73
  • Next page ›
  • Last page »
Displaying 701 - 710 of 721 results

Sign up for email alerts

Stay in the loop with updates on the latest Denali news delivered right to your inbox


  • Investor & Media Relations

CONTACT US

161 Oyster Point Blvd- South San Francisco, CA 94080

© 2025 Denali Therapeutics

  • Privacy Policy
  • Terms of Use

©2025 Denali Therapeutics | 161 Oyster Point Boulevard, South San Francisco, CA 94080

  • Privacy Policy
  • Terms of Use